Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
Baylor College of Medicine
Baylor College of Medicine
Medical College of Wisconsin
Mayo Clinic
Baylor College of Medicine
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
Case Comprehensive Cancer Center
University of Arizona
M.D. Anderson Cancer Center
Baylor College of Medicine
University of Wisconsin, Madison
Murdoch Childrens Research Institute
Baylor College of Medicine
Baylor College of Medicine
Massachusetts General Hospital
Children's National Research Institute
City of Hope Medical Center
Baylor College of Medicine
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Baylor College of Medicine
Children's National Research Institute
Therapeutic Advances in Childhood Leukemia Consortium
Cedars-Sinai Medical Center
Baylor College of Medicine
Stanford University
Ruijin Hospital
OHSU Knight Cancer Institute
City of Hope Medical Center
Beth Israel Deaconess Medical Center
Stanford University
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Peter MacCallum Cancer Centre, Australia
University of Michigan Rogel Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
Masonic Cancer Center, University of Minnesota
Icahn School of Medicine at Mount Sinai
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Tomsk National Research Medical Center of the Russian Academy of Sciences
Washington University School of Medicine